Johanson Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$505K Buy
8,550
+2,152
+34% +$107K 0.15% 86
2021
Q3
$275K Buy
6,398
+202
+3% +$8.95K 0.09% 101
2021
Q2
$248K Buy
6,196
+61
+1% +$2.37K 0.08% 105
2021
Q1
$228K Buy
6,135
+345
+6% +$12.2K 0.08% 105
2020
Q4
$213K Buy
+5,790
New +$212K 0.09% 104
2020
Q1
Sell
-228,571
Closed -$5.54M 200
2019
Q4
$5.54M Buy
+228,571
New +$8.14M 0.26% 60
2019
Q3
Sell
-6,276
Closed -$258K 100
2019
Q2
$258K Buy
6,276
+420
+7% +$16.7K 0.14% 87
2019
Q1
$236K Buy
+5,856
New +$235K 0.13% 91

Other funds holding PFE

Johanson Financial Advisors's PFE Position: Q4 2021 in Review

Johanson Financial Advisors increased its Pfizer (PFE) stake by 34% in Q4 2021, buying an estimated $107K and bringing the position to 8,550 shares worth $505K. The position accounts for 0.15% of the portfolio, ranked #86.

Johanson Financial Advisors first reported a position in PFE in Q1 2019 and has held it in 8 quarters since. The position peaked at $5.54M in Q4 2019. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Johanson Financial Advisors held 8,550 shares of Pfizer worth $505K as of Q4 2021.
  • Johanson Financial Advisors bought 2,152 Pfizer shares in Q4 2021, an estimated $107K.
  • Pfizer made up 0.15% of Johanson Financial Advisors's portfolio in Q4 2021, its #86 holding.
  • Johanson Financial Advisors first reported a position in Pfizer in Q1 2019 and has held it in 8 quarters since.
  • Johanson Financial Advisors's Pfizer position peaked at $5.54M in Q4 2019.
  • 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Johanson Financial Advisors's 13F filing for Q4 2021, filed 19 Jan 2022.